These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 29457868

  • 21. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A, Béhanzin L, Guédou FA, Geraldo N, Goma-Matsétsé E, Giguère K, Aza-Gnandji M, Kessou L, Diallo M, Kêkê RK, Bachabi M, Dramane K, Geidelberg L, Cianci F, Lafrance C, Affolabi D, Diabaté S, Gagnon MP, Zannou DM, Gangbo F, Boily MC, Vickerman P, Alary M.
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [Abstract] [Full Text] [Related]

  • 22. "The Drug Will Help Protect My Tomorrow": Perceptions of Integrating PrEP into HIV Prevention Behaviors Among Female Sex Workers in Lilongwe, Malawi.
    Shea J, Bula A, Dunda W, Hosseinipour MC, Golin CE, Hoffman IF, Miller WC, Go VF, Lungu T, Lancaster KE.
    AIDS Educ Prev; 2019 Oct; 31(5):421-432. PubMed ID: 31550194
    [Abstract] [Full Text] [Related]

  • 23. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR, Yotebieng K, Otticha S, Rota G, Agot K, Ohaga S, Syvertsen JL.
    J Int AIDS Soc; 2019 Apr; 22(4):e25266. PubMed ID: 30983147
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, VOICE-C Study Team.
    J Int AIDS Soc; 2014 Apr; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [Abstract] [Full Text] [Related]

  • 26. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, Jenkins S, Subedar H, Hoke T, Mullick S.
    PLoS One; 2020 Apr; 15(4):e0228620. PubMed ID: 32352969
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs.
    Harris MT, Weinberger E, O'Brien C, Althoff M, Paltrow-Krulwich S, Taylor JL, Judge A, Samet JH, Walley AY, Gunn CM.
    Addict Sci Clin Pract; 2024 Jun 03; 19(1):47. PubMed ID: 38831359
    [Abstract] [Full Text] [Related]

  • 29. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 30. Acceptability of a long-acting injectable HIV prevention product among US and African women: findings from a phase 2 clinical Trial (HPTN 076).
    Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, Pathak S, Bekker LG, Swaminathan S, Stanton J, Farrior J, Sista N.
    J Int AIDS Soc; 2019 Oct 26; 22(10):e25408. PubMed ID: 31651098
    [Abstract] [Full Text] [Related]

  • 31. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G, Folayan M, Undelikwe G, Ochonye B, Jayeoba T, Yusuf A, Aiwonodagbon B, Bilali C, Umoh P, Ojemeiri K, Kalaiwo A.
    BMC Public Health; 2020 Jan 15; 20(1):69. PubMed ID: 31941469
    [Abstract] [Full Text] [Related]

  • 32. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal.
    Sarr M, Gueye D, Mboup A, Diouf O, Bao MDB, Ndiaye AJ, Ndiaye BP, Hawes SE, Tousset E, Diallo A, Jones F, Kane CT, Thiam S, Ndour CT, Gottlieb GS, Mboup S.
    Int J STD AIDS; 2020 Oct 15; 31(11):1063-1072. PubMed ID: 32819210
    [Abstract] [Full Text] [Related]

  • 33. Implementing Differentiated and Integrated HIV Prevention Services for Adolescent Girls and Young Women: Experiences From Oral PrEP Rollout in Primary Care Services in South Africa.
    Butler V, Kutywayo A, Martin CE, Pleaner M, Mojapele MV, Ncube S, Fipaza Z, Mundeta B, Mullick S.
    J Adolesc Health; 2023 Dec 15; 73(6S):S58-S66. PubMed ID: 37953010
    [Abstract] [Full Text] [Related]

  • 34. A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.
    Becquet V, Nouaman M, Plazy M, Agoua A, Zébago C, Dao H, Montoyo A, Jary A, Coffie PA, Eholié S, Larmarange J, the ANRS 12381 PRINCESSE team.
    BMC Public Health; 2021 Dec 04; 21(1):2214. PubMed ID: 34863122
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A Human Rights Case Study on Access to Pre-exposure Prophylaxis for Female Sex Workers in South Africa.
    Winkelman S.
    Health Hum Rights; 2022 Jun 04; 24(1):105-115. PubMed ID: 35747274
    [Abstract] [Full Text] [Related]

  • 38. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland.
    Young I, Flowers P, McDaid LM.
    BMJ Open; 2014 Nov 20; 4(11):e005717. PubMed ID: 25412863
    [Abstract] [Full Text] [Related]

  • 39. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study.
    Beckham SW, Mantsios A, Galai N, Likindikoki S, Mbwambo J, Davis W, Kerrigan D.
    BMJ Open; 2022 Aug 17; 12(8):e058611. PubMed ID: 35977762
    [Abstract] [Full Text] [Related]

  • 40. Motivating factors associated with oral pre-exposure prophylaxis use among female sex workers in South Africa.
    Makhakhe NF, MeyerWeitz A, Sliep Y.
    J Health Psychol; 2022 Oct 17; 27(12):2820-2833. PubMed ID: 34991407
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.